Most patients reach plateau effectiveness here
A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society explicitly states that restrictive eating disorder is a general contraindication to GLP-1 use and that individuals with a history of eating disorders should be referred to an eating disorders specialist before these medications are prescribed ( Mozaffarian et al., Am J Clinical Nutrition, 2025 )
Based on current evidence, injectable semaglutide and injectable tirzepatide have the most lactation safety data
Once-daily NPH insulin to once-daily SEMGLEE, the recommended starting SEMGLEE dosage is the same as the dosage of NPH that is being discontinued
Thyroid C-Cell Tumors - The risk of thyroid c-cell tumors (carcinomas and adenomas) had been exposed to rats and mice after Semaglutide treatment
The Medical Weight Loss Program at New Concept Healthcare | Functional Medicine Gaffney